Upgrade to SI Premium - Free Trial

Evoke Pharma (EVOK) Tops Q2 EPS by 4c

August 14, 2017 4:10 PM

Evoke Pharma (NASDAQ: EVOK) reported Q2 EPS of ($0.11), $0.04 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

Categories

Earnings Guidance